LFG
SNDX icon

Larson Financial Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Larson Financial Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.6K Sell
2,313
-281
-11% -$5.84K ﹤0.01% 1519
2026
Q1 		$60.6K Buy
2,594
+224
+9% +$4.87K ﹤0.01% 1250
2025
Q4 		$49.8K Sell
2,370
-552
-19% -$9.63K ﹤0.01% 1228
2025
Q3 		$45K Buy
2,922
+1,922
+192% +$25.2K ﹤0.01% 1206
2025
Q2 		$9.37K Sell
1,000
-24
-2% -$264 ﹤0.01% 1834
2025
Q1 		$12.6K Buy
1,024
+24
+2% +$339 ﹤0.01% 1549
2024
Q4 		$13.2K Hold
1,000
– – ﹤0.01% 1384
2024
Q3 		$19.3K Buy
+1,000
New +$20.7K ﹤0.01% 1230

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Larson Financial Group's SNDX Position: Q2 2026 in Review

Larson Financial Group reduced its Syndax Pharmaceuticals (SNDX) stake by 11% in Q2 2026, selling an estimated $5.84K and leaving 2,313 shares worth $50.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

Larson Financial Group first reported a position in SNDX in Q3 2024 and has held it in 8 quarters since. The position peaked at $60.6K in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Larson Financial Group held 2,313 shares of Syndax Pharmaceuticals worth $50.6K as of Q2 2026.
  • Larson Financial Group sold 281 Syndax Pharmaceuticals shares in Q2 2026, an estimated $5.84K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1519 holding.
  • Larson Financial Group first reported a position in Syndax Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Larson Financial Group's Syndax Pharmaceuticals position peaked at $60.6K in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.